Baxter (NYSE:BAX) agreed to pay $18 million to settle criminal and civil cases stemming from a North Carolina sterile intravenous solution plant where mold was found in air filters.
The agreement includes penalties and forfeitures of some $16 million and another $2.2 million to settle a civil qui tam lawsuit with the U.S. Justice Dept. Whistleblower Christopher Wall, who filed the False Claims suit, is due to receive about $432,000 from the case, according to the Justice Dept.
Get the full story at our sister site, Drug Delivery Business News.